755 related articles for article (PubMed ID: 23321003)
1. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro.
Li L; Liu J; Yan X; Qin K; Shi M; Lin T; Zhu Y; Kang T; Zhao G
J Ethnopharmacol; 2011 Oct; 138(1):135-41. PubMed ID: 21945003
[TBL] [Abstract][Full Text] [Related]
3. [Ginsenoside Rbl attenuates beta-amyloid peptide25-35 -induced tau hyperphosphorylation in cortical neurons].
Zeng YQ; Chen XC; Zhu YG; Li YK; Peng XS; Chen LM; Shen J; Huang TW
Yao Xue Xue Bao; 2005 Mar; 40(3):225-30. PubMed ID: 15952593
[TBL] [Abstract][Full Text] [Related]
4. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia.
Zhang X; Shi M; Ye R; Wang W; Liu X; Zhang G; Han J; Zhang Y; Wang B; Zhao J; Hui J; Xiong L; Zhao G
Neurochem Res; 2014 Jul; 39(7):1363-73. PubMed ID: 24792734
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
7. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
8. [Abeta(25-35) and ginsenoside Rb1 influence on the expression of GSK-3beta, CDK-5 and PP2A in differentiated neural stem cells of rats].
Zhao QX; Yan WH; Han XF; Xu Y; Xing Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 May; 26(2):187-90. PubMed ID: 20684275
[TBL] [Abstract][Full Text] [Related]
9. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.
Huang HC; Tang D; Xu K; Jiang ZF
J Recept Signal Transduct Res; 2014 Feb; 34(1):26-37. PubMed ID: 24188406
[TBL] [Abstract][Full Text] [Related]
10. Selective loss of basal forebrain cholinergic neurons by 192 IgG-saporin is associated with decreased phosphorylation of Ser glycogen synthase kinase-3beta.
Hawkes C; Jhamandas JH; Kar S
J Neurochem; 2005 Oct; 95(1):263-72. PubMed ID: 16181430
[TBL] [Abstract][Full Text] [Related]
11. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
13. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of donepezil against Aβ42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3β and nAChRs activity.
Noh MY; Koh SH; Kim SM; Maurice T; Ku SK; Kim SH
J Neurochem; 2013 Nov; 127(4):562-74. PubMed ID: 23711227
[TBL] [Abstract][Full Text] [Related]
15. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
17. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.
Annamalai B; Won JS; Choi S; Singh I; Singh AK
Biochem Biophys Res Commun; 2015 Feb; 458(1):214-9. PubMed ID: 25640839
[TBL] [Abstract][Full Text] [Related]
18. Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms.
Liu GP; Zhang Y; Yao XQ; Zhang CE; Fang J; Wang Q; Wang JZ
Neurobiol Aging; 2008 Sep; 29(9):1348-58. PubMed ID: 17433504
[TBL] [Abstract][Full Text] [Related]
19. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
Chauhan NB; Siegel GJ; Feinstein DL
Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731
[TBL] [Abstract][Full Text] [Related]
20. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
